Lunai Bioworks Inc (LNAI)
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
$0.16-30.20%
Close 2026-10-29 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
QuarterlyIQ Insights · LNAI
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 667.2% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Model as of —
LNAI — CFO transition
Dated 2026-10-22
CFO — Nathen Fuentes: The immediate resignation of the CFO without a named successor or interim officer represents a significant loss of senior management and creates uncertainty regarding financial reporting capabilities.
Why it matters: Nasdaq trading is set to stop, and the company plans to leave the exchange. The filing and delisting dates will show whether that plan moves ahead.
Worry ifA Form 25 is filed around November 2. Nasdaq delisting starts around November 12, 2026.
Less concerning ifThe company says it withdrew or delayed the Form 25 filing. Or Nasdaq trading continues past the stated dates.
Why it matters: The company plans to seek a pause in SEC reports after leaving Nasdaq. A filing would reduce public updates about its finances and plans.
Worry ifThe company files Form 15 and says SEC rules suspend or end its SEC reporting duties.
Less concerning ifThe company does not file Form 15, or it says SEC reporting duties remain in place.
Why it matters: The CFO's quick exit leaves a key finance role open. Naming a successor can show who is responsible for the company's financial reports.
Watch forThe company names a new CFO or interim CFO in a public filing or release.
Also watch forThe company reports no CFO or interim CFO, or says the role remains open in its next filing.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$387 on $10,000 · ±3.9% | How much price usually moves either way. |
| Bad day | $1,558 loss on $10,000 · 15.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,863 loss on $10,000 · 98.6% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.